Canonical: https://ownershiptrace.com/13f/companies/2492

# Who owns ARS Pharmaceuticals, Inc. (ALTUQ)? Elite investor 13F holders

3 tracked elite investors reported holding ARS Pharmaceuticals, Inc as of 2026-06-30, including Rubric Capital, Third Point, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Rubric Capital](https://ownershiptrace.com/13f/investors/120) | Ars Pharmaceuticals Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 68412297.00 USD | 8540861.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1687509/0001104659-26-097098-index.html) |
| [Third Point](https://ownershiptrace.com/13f/investors/22) | Ars Pharmaceuticals Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8010000.00 USD | 1000000.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1040273/0001040273-26-000003-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | Ars Pharmaceuticals Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 367619.00 USD | 45895.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Ars Pharmaceuticals Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)